Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solo Brands (SBDS) Cash & Equivalents (2021 - 2025)

Historic Cash & Equivalents for Solo Brands (SBDS) over the last 5 years, with Q3 2025 value amounting to $16.3 million.

  • Solo Brands' Cash & Equivalents rose 3073.48% to $16.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.3 million, marking a year-over-year increase of 3073.48%. This contributed to the annual value of $12.0 million for FY2024, which is 3962.3% down from last year.
  • Latest data reveals that Solo Brands reported Cash & Equivalents of $16.3 million as of Q3 2025, which was up 3073.48% from $18.1 million recorded in Q2 2025.
  • In the past 5 years, Solo Brands' Cash & Equivalents ranged from a high of $206.4 million in Q1 2025 and a low of $9.5 million during Q3 2021
  • In the last 5 years, Solo Brands' Cash & Equivalents had a median value of $18.1 million in 2025 and averaged $31.8 million.
  • Per our database at Business Quant, Solo Brands' Cash & Equivalents tumbled by 6683.33% in 2024 and then soared by 123930.31% in 2025.
  • Quarter analysis of 5 years shows Solo Brands' Cash & Equivalents stood at $25.1 million in 2021, then decreased by 7.2% to $23.3 million in 2022, then fell by 14.82% to $19.8 million in 2023, then crashed by 39.62% to $12.0 million in 2024, then surged by 36.34% to $16.3 million in 2025.
  • Its Cash & Equivalents was $16.3 million in Q3 2025, compared to $18.1 million in Q2 2025 and $206.4 million in Q1 2025.